Ethics declarations Conflict of interest The authors declared no competing interests
Mounjaro is a weekly injectable weight-loss drug for adults with obesity or overweight plus another weight-related condition
One subject of the present invention is therefore the combination of acetyl L-carnitine, propionyl L-carnitine, or one of their pharmaceutically acceptable salts, with one or more drugs useful for the treatment of erectile dysfunction
The nasal spray format was not chosen for convenience, but for its utility in modeling alternative delivery pathways - especially in metabolic or neuroendocrine research scenarios
Trulicty makes a claim that 94% of adults say it was easy to use thanks to their preloaded pens
This story mentions weight, weight loss, and/or prescription GLP-1 drugs, which are FDA-approved for weight management in adults diagnosed with obesity or with overweight and at least one weight-related health condition